The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner